Serotypes and extended-spectrum β-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 1, 2011, Pages 98-104

  Zhang, Rong ^a,c   Zhou, Hong Wei ^a   Cai, Jia Chang ^a   Zhang, Jun ^b   Chen, Gong Xiang ^a   Nasu, Masao ^c   Xie, Xin you ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CTX M type; Extended spectrum lactamases; Serotype; Shigella spp.

Indexed keywords

AMPICILLIN; AZTREONAM; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULPERAZON;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; CTX M 14 GENE; CTX M 15 GENE; DNA SEQUENCE; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHINA; DNA FINGERPRINTING; DNA, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; ISOELECTRIC FOCUSING; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; SEQUENCE ANALYSIS, DNA; SEROTYPING; SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 78649926885     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.08.027     Document Type: Article

References (41)

1. Acikgoz Z.C., Gulay Z., Bicmen M., Gocer S., Gamberzade S. CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand. J. Infect. Dis. 2003, 35:503-505.
2. Ahamed J., Kundu M. Molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob. Agents Chemother. 1999, 43:2081-2083.
3. Andres P., Petroni A., Faccone D., Past é ran F., Melano R., Rapoport M., Mart í nez M., Culasso C., Bella A.D., Irigoyen B., Mulki J., Procopio A. Extended-spectrum β-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int. J. Antimicrob. Agents 2005, 5:501-507.
4. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 2004, 48:1-14.
5. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin. Microbiol. Rev. 2001, 14:933-951.
6. Chen L., Chen H.Z., Mo C.J. The distribution of 55 strains of Bacillus dysenteriae and results of drug sensitivity tests. China Tropical Medicine 2006, 6:2049-2050.
7. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 17th informational supplement (M100-S17) 2007, CLSI, Wayne, PA.
8. Egah D.Z., Banwat E.B., Audum E.S., Allanana J.A., Danung M.L., Damen J.G., Badung B.P. Multiple drug resistant strains of Shigella isolated in Jos, central Nigeria. Niger. Postgrad. Med. J. 2003, 10:154-156.
9. Flores A., Araque M., Vizcaya L. Multiresistant Shigella species isolated from pediatric patients with acute diarrheal disease. Am. J. Med. Sci. 1998, 316:379-384.
10. Hata M., Suzuki M., Matsumoto M., Takahashi M., Sato K., Ibe S., Sakae K. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 2005, 49:801-803.
11. Huang I.F., Chiu C.H., Wang M.H., Wu C.Y., Hsieh K.S., Chiou C.C. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC β-lactamase resistance in S. sonnei. J. Clin. Microbiol. 2005, 43:2608-2612.
12. Jennison A.V., Roberts F., Verma N.K. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity. FEMS Immunol. Med. Microbiol. 2006, 46:444-445.
13. Jin Y.H., Oh Y.H., Jung J.H., Kim S.J., Kim J.A., Han K.Y., Kim M.Y., Park S.G., Lee Y.K. Antimicrobial resistance patterns and characterization of integrons of Shigella sonnei isolates in Seoul, 1999-2008. J. Microbiol. 2010, 48:236-242.
14. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W.H.O 1999, 77:651-666.
15. Lartigue M.F., Poirel L., Decousser J.W., Nordmann P. Multidrug-Resistant Shigella sonnei and Salmonella enterica serotype Typhimurium isolates producing CTX-M β-lactamases as causes of community-acquired infection in France. Clin. Infect. Dis. 2005, 40:1069-1071.
16. Lee J.C., Oh J.Y., Kim K.S., Jeong Y.W., Cho J.W., Park J.C., Seol S.Y., Cho D.T. Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 2001, 109:228-234.
17. Lima A.A., Lima N.L., Pinho M.C., Barros Junior E.A., Teixeira M.J., Martins M.C., Guerrant R.L. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993. Antimicrob. Agents Chemother. 1995, 39:256-259.
18. López E.L., Prado-Jiménez V., O'Ryan-Gallardo M., Contrini M.M. Shigella and shiga toxin-producing Escherichia coli causing bloody diarrhea in Latin America. Infect. Dis. Clin. North Am. 2000, 14:41-65.
19. Maraki S., Georgiladakis A., Christidou A., Scoulica E., Tselentis Y. Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995. APMIS 1998, 106:879-883.
20. Matthew M., Harris M., Marshall M.J., Rose G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 1975, 88:169-178.
21. Nicolas F., Thierry N., Olivier G., Patrice N. SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate. J. Antimicrob. Chemother. 2001, 47:685-688.
22. O'Hara K., Haruta S., Sawai T., Tsunoda M., Iyobe S. Novel metallo β-lactamase mediated by a Shigella flexneri plasmid. FEMS Microbiol. Lett. 1998, 162:201-206.
23. Pai H., Choi E.H., Lee H.J., Hong J.Y., Jacoby G.A. Identification of CTX-M-14 Extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J. Clin. Microbiol. 2001, 39:3747-3749.
24. Qin E.Q., Zhang X. Analysis of the group distribution and drug sensitivity in 116 patients with shigellosis. Beijing Medical J. 2006, 28:609-610.
25. Qu F., Wang H.Q., Cui E.B., Xia G.M., Bao C.M., Guo J.X., Mao Y.L. Distribution and resistance of enteric pathogenic bacteria in Beijing area. Chinese J. Infect. Dis. 2002, 20:346-348.
26. Shannon K.P., King A., Phillips I., Nicolas M.H., Philippon A. Importance of organisms producing broad-spectrum SHV-group β-lactamases in the United Kingdom. J. Antimicrob. Chemother. 1990, 25:343-351.
27. Sirot D., Chanal C., Bonnet R., De Champs C., Sirot J., Bret L. Inhibitor-resistant TEM-33 β-lactamase in a Shigella sonnei isolate. Antimicrob. Agents Chemother. 2001, 45:2179-2180.
28. Siu L.K., Ho P.L., Yuen K.Y., Wong S.S., Chau P.Y. Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box. Antimicrob. Agents Chemother. 1997, 41:468-470.
29. Siu L.K., Lo J.Y.C., Yuen K.Y., Chau P.Y., Ng M.H., Ho P.L. β-Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30. Antimicrob. Agents Chemother. 2000, 44:2034-2038.
30. Soldati L., Piffaretti J.C. Molecular typing of Shigella strains using pulsed field gel electrophoresis and genome hybridization with insertion sequences. Res. Microbiol. 1991, 142:489-498.
31. Stelling J., Yih W.K., Galas M., Kulldorff M., Pichel M., Terragno R., Tuduri E., Espetxe S., Binsztein N., O'Brien T.F., Platt R. Automated use of WHONET and SaTScan to detect outbreaks of Shigella spp. using antimicrobial resistance phenotypes. Epidemiol. Infect. 2009, 138:873-883. Collaborative Group WHONET-Argentina.
32. Streit J.M., Jones R.N., Toleman M.A., Stratchounski L.S., Fritsche T.R. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int. J. Antimicrob. Agents. 2006, 27:367-375.
33. Sumathi S., Nelson J.M., Joyce K., Hoekstra M., Angulo F.J., Mintz E.D. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob. Agents Chemother. 2006, 50:49-54.
34. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial isolate typing. J. Clin. Microbiol. 1995, 33:2233-2239.
35. Vinh H., Nhu N.T., Nga T.V., Duy P.T., Campbell J.I., Hoang N.V., Boni M.F., My P.V., Parry C., Nga T.T., Van Minh P., Thuy C.T., Diep T.S., Phuong le T., Chinh M.T., Loan H.T., Tham N.T., Lanh M.N., Mong B.L., Anh V.T., Bay P.V., Chau N.V., Farrar J., Baker S. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009, 9:204.
36. Wong M.R., Reddy V., Hanson H., Johnson K.M., Tsoi B., Cokes C., Gallagher L., Lee L., Plentsova A., Dang T., Krueger A., Joyce K., Balter S. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009. Microb. Drug Resist. 2010, 16:155-161.
37. Xiong Z.Z., Li H., Li T., Xu Y.H., Li J. The genotype of extended-spectrum β-lactamases in Shigella flexneri isolates. Chin. J. Infect. Dis. 2006, 24:296-300.
38. Xiong Z.Z., Li T., Li H., Xu Y.H., Li J. Detection of extended-spectrum β-lactamases in Shigella sonnei isolates. Chin. J. Infect. Chemother. 2006, 6:172-175.
39. Xiong Z., Li J., Li T., Shen J., Hu F., Wang M. Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. J. Antibiot. (Tokyo) 2010, 63:187-189.
40. Ye J.L., Zhu S.R., Mo S.T., Luo Y., Meng Z. Analysis on Distribution of shigella dysenteriae flora and drug resistance in 2003 in partial regions of Zhejiang Province. Dis. Surveill. 2005, 20:80-81.
41. Yu Y.S., Yang Q.X., Xu W., Kong H.S., Xu G.Y., Zhong B.Y. Typing and characterization of carbapenem resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J. Med. Microbiol. 2004, 53:653-656.